Orthobiologics
33 places
Worldwide report
Every place
- 33Reports naming them
- 1Markets they lead in
- 33Regions & countries
- 7Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Orthofix Medical or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Where they show up
33 reportsOur reports that name Orthofix Medical as a key player, by category and place.
- Medical Devices · 33
Places 33
- Africa 1
- APAC 1
- Australia 1
- Brazil 1
- Canada 1
- China 1
- Ecuador 1
- Egypt 1
- Europe 1
France 1- Germany 1
- Global 1
Hong Kong 1
India 1
Italy 1
Japan 1
Kenya 1- Latin America 1
Malaysia 1
Mexico 1- Middle East 1
New Zealand 1- North America 1
Philippines 1
Russia 1
Saudi Arabia 1
Singapore 1
South Africa 1
Spain 1
Thailand 1- UAE 1
UK 1
US 1
Orthofix Medical's markets
1Markets where they are a key player. Each opens the market's statistics for every place we cover.
Medical Devices1
None of their markets match.
Recent reports naming Orthofix Medical
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
33 places
Companies they compete with most
Named as key players in the same markets as Orthofix Medical (number of shared markets).
Bioventus1 shared market
Medtronic1 shared market
Stryker1 shared market
Zimmer Biomet Holdings, Inc.1 shared market
Medtronic1 shared market
Stryker1 shared market
Zimmer Biomet Holdings, Inc.1 shared market
Free public data on Orthofix Medical
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Stock listing
- NASDAQ: OFIX
- Type
- Medical devices
Source: SEC EDGAR, Company filings, CIK 884624. Retrieved 13 Nov 2026.
Clinical trials
7 active studies led by Orthofix Medical, of 27 in all
Source: ClinicalTrials.gov, Studies with Orthofix Medical (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
US device clearances
70 510(k) clearances and PMA approvals since 2015
- Fitbone® Transport And Lengthening System K260146 · 19 May 2026
- Fitbone™ Trochanteric, Fitbone® Transport And Lengthening System, Fitbone® Taa K253991 · 8 May 2026
- Firebird Si Navigation System K252088 · 31 Oct 2025
- Fitbonetm Trochanteric K250112 · 10 Apr 2025
- Accelstimtm Bone Growth Stimulator Stimulator, Bone Growth, Non-Invasive Accels… P210035 · 21 Mar 2025
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
US recalls
61 recalls since 2015 (61 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
SEC filings
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 884624.
Trials over time
Studies Orthofix Medical leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Orthofix Medical or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Topics
The topics of the markets Orthofix Medical is in.
From our blog
Stories on the topics Orthofix Medical works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Vitamin D: Deficiency, Testing and Supplements
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read
Collagen Supplements: Skin, Joints and Real Evidence
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read